Helen Blair

993 total citations
19 papers, 545 citations indexed

About

Helen Blair is a scholar working on Molecular Biology, Hematology and Urban Studies. According to data from OpenAlex, Helen Blair has authored 19 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Urban Studies. Recurrent topics in Helen Blair's work include Acute Myeloid Leukemia Research (7 papers), Cultural Industries and Urban Development (6 papers) and Protein Degradation and Inhibitors (3 papers). Helen Blair is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Cultural Industries and Urban Development (6 papers) and Protein Degradation and Inhibitors (3 papers). Helen Blair collaborates with scholars based in United Kingdom, Netherlands and United States. Helen Blair's co-authors include Keith Randle, Nigel Culkin, Al Rainnie, Olaf Heidenreich, Abhishek Sharma, Sarah Wilkinson, Britta Vormoor, David R. Newell, Nicola J. Curtin and Michael Heuser and has published in prestigious journals such as Blood, Cancer Research and Cell Reports.

In The Last Decade

Helen Blair

19 papers receiving 489 citations

Peers

Countries citing papers authored by Helen Blair

Since Specialization

Citations

This map shows the geographic impact of Helen Blair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Blair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Blair more than expected).

Fields of papers citing papers by Helen Blair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Blair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Blair. The network helps show where Helen Blair may publish in the future.

Co-authorship network of co-authors of Helen Blair

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Blair. A scholar is included among the top collaborators of Helen Blair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Blair. Helen Blair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1 2024 ·iScience ·Daniel Coleman, Peter Keane, Paulynn Suyin Chin, (unknown), (unknown), Helen Blair, Naeem Khan, James D. Griffin, Elizabeth A. Holmes, (unknown), Sandeep Potluri, (unknown), (unknown), Manoj Raghavan, John H. Bushweller, Olaf Heidenreich, (unknown), Peter N. Cockerill, Constanze Bonifer	7
2	MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma 2024 ·Neuro-Oncology ·(unknown), (unknown), Janet C. Lindsey, (unknown), Alaide Morcavallo, Florence Burté, Rebecca M. Hill, Helen Blair, (unknown), (unknown), (unknown), Stephen Crosier, Tong Zhang, Oliver D.K. Maddocks, Andrew C. Peet, Louis Chesler, Ian Hickson, Ross J. Maxwell, Steven C. Clifford	3
3	The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML 2023 ·HemaSphere ·(unknown), Helen Blair, (unknown), Katarzyna Szołtysek, Rachel Cameron, (unknown), Anja Krippner‐Heidenreich, Florian Grebien, Gerard M. McGeehan, C. Michel Zwaan, Olaf Heidenreich	17
4	Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia 2023 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), Sirintra Nakjang, Nidhi Jyotsana, (unknown), Michael Heuser, Helen Blair, Olaf Heidenreich	17
5	Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth 2023 ·Cell Reports ·Daniel Coleman, Peter Keane, (unknown), Paulynn Suyin Chin, Helen Blair, (unknown), (unknown), James D. Griffin, Elizabeth A. Holmes, Sandeep Potluri, Salam A. Assi, John H. Bushweller, Olaf Heidenreich, Peter N. Cockerill, Constanze Bonifer	6
6	Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia Model 2020 ·Molecular Cancer Research ·(unknown), Stefanie Bertram, Helen Blair, Verena Börger, Guntram Büsche, (unknown), (unknown), Bernd Giebel, Olaf Heidenreich, (unknown), Laxmikanth Kollipara, (unknown), Albert Sickmann, Christiane Walter, Nils von Neuhoff, Helmut Hanenberg, Dirk Reinhardt, Markus Schneider, Mareike Rasche	2
7	Paediatric Burkitt lymphoma patient‐derived xenografts capture disease characteristics over time and are a model for therapy 2020 ·British Journal of Haematology ·(unknown), Jamie D. Matthews, Leila Jahangiri, Liam C. Lee, Nina Prokoph, Tim Malcolm, Olivier Giger, (unknown), Helen Blair, Aengus O’Marcaigh, Owen Smith, Lukas Kenner, Simon Bomken, (unknown), Suzanne D. Turner	5
8	Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 2018 ·Haematologica ·Paul Sinclair, Helen Blair, Sarra Ryan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Matthew Bashton, Claire Schwab, Lisa Jones, Lisa J. Russell, Helen Marr, Peter Carey, Christina Halsey, Olaf Heidenreich, Anthony V. Moorman, Christine J. Harrison	9
9	Functional characterisation of a novel ovarian cancer cell line, NUOC-1 2017 ·Oncotarget ·(unknown), (unknown), (unknown), Gavin Cuthbert, R O’Donnell, Brian T. Wilson, (unknown), (unknown), Huw D. Thomas, Helen Blair, Sarah Fordham, John Lunec, James M. Allan, Richard J. Edmondson	3
10	Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2 2017 ·Oncotarget ·Britta Vormoor, (unknown), Helen Blair, Abhishek Sharma, Sarah Wilkinson, David R. Newell, Nicola J. Curtin	24
11	Abstract 325: Evaluating the consequences of MCT1 inhibition in Burkitt lymphoma following treatment with AZD3965 2016 ·Cancer Research ·(unknown), (unknown), Helen Blair, Huw D. Thomas, Simon Bomken, Susan E. Critchlow, Stephen R. Wedge	1
12	RAS Pathway Mutations Are Highly Prevalent In Relapsed Childhood Acute Lymphoblastic Leukaemia, Are Frequently Relapse-Drivers and Confer Sensitivity To MEK Inhibition 2013 ·Blood ·Julie Irving, Elizabeth Matheson, Lynne Minto, Helen Blair, Marian Case, Christina Halsey, (unknown), Frida Ponthan, Renate Kirschner‐Schwabe, Stefanie Groeneveld‐Krentz, Jana Hof, James R. Allan, Christine J. Harrison, Josef Vormoor, Arend von Stackelberg, Cornelia Eckert	2
13	From London to Los Angeles: a comparison of local labour market processes in the US and UK film industries 2003 ·The International Journal of Human Resource Management ·Helen Blair, Nigel Culkin, Keith Randle	34
14	Winning and Losing in Flexible Labour Markets: the Formation and Operation of Networks of Interdependence in the UK Film Industry 2003 ·Sociology ·Helen Blair	49
15	`You're only as Good as Your Last Job': The Labour Process and Labour Market in the British Film Industry 2001 ·Work Employment and Society ·Helen Blair	156
16	‘You're Only as Good as Your Last Job’: the Labour Process and Labour Market in the British Film Industry 2001 ·Work Employment and Society ·Helen Blair	110
17	Working in film – Employment in a project based industry 2001 ·Personnel Review ·Helen Blair, (unknown), Keith Randle	69
18	Flexible films? 2000 ·Media Culture & Society ·Helen Blair, Al Rainnie	18
19	A pernicious panacea—a critical evaluation of business re‐engineering 1998 ·New Technology Work and Employment ·Helen Blair, (unknown), Keith Randle	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact